2003
DOI: 10.1046/j.1398-9995.2003.00323.x
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term repeatability of the skin prick test is high when supported by history or allergen‐sensitivity tests: a prospective clinical study

Abstract: Background: Long‐term reproducibility of the skin‐prick test (SPT) has been questioned. The aim of the study was to investigate the clinical relevance of SPT changes.Methods: SPT to 10 common inhalation allergens was performed annually from 1999 to 2001 in 25 nonsensitized and 21 sensitized subjects. An SPT was positive when ≥3 mm, and repeatable if either persistently positive or negative. Clinical sensitivity to birch pollen was used as model for inhalation allergy, and was investigated at inclusion and at s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
11
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 21 publications
1
11
0
Order By: Relevance
“…9 To our knowledge, no study on s-IgE remission has been published. We observed remission of sensitization (s-IgE class <2 at follow-up) in 11% (n = 36) of sensitized subjects (s-IgE class 2 at baseline; Table III).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…9 To our knowledge, no study on s-IgE remission has been published. We observed remission of sensitization (s-IgE class <2 at follow-up) in 11% (n = 36) of sensitized subjects (s-IgE class 2 at baseline; Table III).…”
Section: Discussionmentioning
confidence: 99%
“…7 Remission of sensitization assessed on the basis of skin prick tests in adult and pediatric populations is reported in 1% to 20% of subjects with positive skin test responses. 9 However, there are few published data on remission of AR and of positive levels of serum s-IgE.…”
mentioning
confidence: 99%
“…The risk of allergy onset was conferred solely to the latter. It can be speculated that the former represents a state of transient SPT sensitisation [33,34] or a very early condition that over time progresses to increased allergen susceptibility. Could this be represented by the few subjects with insignificant symptoms?…”
Section: Discussionmentioning
confidence: 99%
“…The reduction in symptom scores shows the magnitude of clinical efficacy, and it is decisive to prove a significant difference between the treatment and placebo groups (1). Five other studies demonstrate significant improvements in symptom scores within treatment periods of 12–24 months (8, 10, 12–14). The clinical documentation of the efficacy of SLIT is affected by the duration of the treatment, amount of allergen administrated, and the criteria for patient selection.…”
Section: Discussionmentioning
confidence: 99%